NTRB News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

NT

Mkt Cap

$77.0M

Volume

23.80K

Next Earnings

December 9th

Loading chart

NT

NTRBNutriband Inc. Common Stock

NTRB

Pay with—

Available Balance0.00

NT

Mkt Cap

$75.6M

Volume

23.80K

Next Earnings

December 9th

Chart Financials Earnings News About Insider Filings

Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory BoardNutriband Inc. announced the appointment of former Navy SEAL Robert J. O'Neill to its Advisory Board. O'Neill, a decorated veteran and advocate for veterans' health, brings expertise in leadership and decision-making. His appointment supports Nutriband's advancement of AVERSA, an abuse-deterrent fentanyl patch candidate under development.GlobeNewswire Inc. · Sep 25, 2026

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion PointsNutriband Inc. announced key milestones from its January 2026 Annual Shareholders Meeting, including the addition of two new directors with strong financial and operational backgrounds. The company reported progress on its AVERSA™ abuse-deterrent fentanyl patch development, including patent grants, manufacturing scale-up completion, and FDA Type C meeting. However, the proposed sale of its Pocono Pharma subsidiary to EarthVision Bio remains incomplete, with the company collecting weekly penalty payments. Nutriband also filed a FINRA complaint regarding suspected naked short selling and reminded shareholders of warrant expiration in October 2026.GlobeNewswire Inc. · Jan 30, 2026

Nutriband CEO Publishes Letter to ShareholdersNutriband Inc. reported significant progress in 2025 including the sale of 90% of its Pocono subsidiary to EarthVision Bio for $5M with no shareholder dilution, a 25% preferred stock dividend, and major advances in its lead product AVERSA Fentanyl abuse-deterrent patch. The company received FDA Type C Meeting approval, completed manufacturing scale-up, secured additional patents, and was added to four Russell indexes. The CEO highlighted shareholder value focus and anticipated warrant expiration in October 2026 as a potential positive catalyst.GlobeNewswire Inc. · Dec 31, 2025

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision BioNutriband Inc. announced the sale of a 90% stake in its subsidiary Pocono Pharmaceutical to EarthVision Bio for $5 million USD, with Nutriband shareholders retaining 10% ownership. The company plans to use proceeds to develop AVERSA Fentanyl, an abuse-deterrent opioid patch with potential annual US sales of $80-200 million. EarthVision Bio is developing sustainable product alternatives founded by Intel co-founder Dr. Gordon Moore and ex-Chevron Europe chairman Dr. Hans Franke.GlobeNewswire Inc. · Dec 29, 2025

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl PatchNutriband met with the FDA to discuss its AVERSA™ FENTANYL abuse deterrent patch, receiving guidance on regulatory pathway, manufacturing, and clinical study plans for a potential first-of-its-kind worldwide abuse deterrent fentanyl patch.GlobeNewswire Inc. · Oct 28, 2025

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl PatchNutriband has partnered with Brand Institute to develop a commercial brand name for its lead product, an abuse deterrent fentanyl transdermal patch utilizing AVERSA™ technology, aimed at preventing drug misuse and accidental exposure.GlobeNewswire Inc. · Oct 10, 2025

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live streamEmergingGrowth.com announced the schedule for its 85th conference featuring presentations from multiple public companies across various sectors on August 20-21, 2025, providing insights into emerging growth companies.GlobeNewswire Inc. · Aug 20, 2025

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl PatchNutriband Inc. received FDA meeting approval to discuss Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL, an abuse-deterrent fentanyl patch developed in partnership with Kindeva. The product aims to prevent drug abuse and misuse while maintaining patient accessibility.GlobeNewswire Inc. · Aug 8, 2025

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA ApprovalNutriband Inc. announced a 25% preferred stock dividend for shareholders, with record date on July 25th, 2025 and pay date on August 5th. The preferred shares are convertible to common stock upon FDA approval of their AVERSA Fentanyl product.Benzinga · Jul 18, 2025

Nutriband Signs Partnership Agreement with Charlotte FCNutriband Inc., a developer of transdermal pharmaceutical products, has signed an Associate Partnership agreement with Charlotte FC. The company plans to use the partnership to build visibility for its AI Tape product, which is manufactured locally in the Charlotte area, and to promote its AVERSA abuse deterrent patch technology.GlobeNewswire Inc. · Apr 4, 2025

to start trading

NT

NTRBNutriband Inc. Common Stock

NTRB

Pay with—

Available Balance0.00

Your PositionYou don't own any NTRB yet.

Related Tickers

Earnings